Welcome Stockaholics!

We are a new and fast growing financial forum! Sign up for free and let's talk stocks!

  1. Do you want to help develop this community? We are looking for contributions from investors and traders like you! What stocks do you follow? What is hot right now? Sign up and get in on the ground floor of the newest, fastest growing financial forum!
    Dismiss Notice
  2. You will notice a live chat widget on the right. Click in to join us and lets hear about how you nailed that last UWTI trade!
    Dismiss Notice

LLY - Eli Lilly & Company

Discussion in 'Stock Message Boards NYSE, NASDAQ, AMEX' started by T0rm3nted, Apr 26, 2016.

  1. T0rm3nted

    T0rm3nted Moderator
    Staff Member

    Joined:
    Apr 2, 2016
    Messages:
    7,448
    Likes Received:
    2,453
    [​IMG]
    Eli Lilly and Company (LLY) is an American global pharmaceutical company with headquarters located in Indianapolis, Indiana, in the United States. The company also has offices in Puerto Rico and 17 other countries. Their products are sold in approximately 125 countries. The company was founded in 1876 by Col. Eli Lilly, a pharmaceutical chemist and veteran of the American Civil War, after whom the company was named.

    Among other specialties, Lilly was the first company to mass-produce penicillin, the Salk polio vaccine, and insulin, including one of the first pharmaceutical companies to produce human insulin using recombinant DNA. Lilly is also the world's largest manufacturer and distributor of psychiatric medications.

    In 2009, Eli Lilly pleaded guilty to illegally marketing the drug Zyprexa for off-label uses not approved by the U.S. Food and Drug Administration, particularly the treatment of dementia in the elderly. The company paid a $515 million criminal fine, at the time the largest in history.
     
  2. T0rm3nted

    T0rm3nted Moderator
    Staff Member

    Joined:
    Apr 2, 2016
    Messages:
    7,448
    Likes Received:
    2,453
    Reported before open today (4/26/16)
    Earnings: EPS $0.83 Revenue $4.865B
    Estimates: EPS $0.85 Revenue $4.875B
     
  3. T0rm3nted

    T0rm3nted Moderator
    Staff Member

    Joined:
    Apr 2, 2016
    Messages:
    7,448
    Likes Received:
    2,453
    Reported before open today (7/26/16)
    Earnings: EPS $0.86 Revenue $5.4B
    Estimates: EPS $0.86 Revenue $5.15B

    Up 0.13% today
     
  4. T0rm3nted

    T0rm3nted Moderator
    Staff Member

    Joined:
    Apr 2, 2016
    Messages:
    7,448
    Likes Received:
    2,453
    Reported before open today (10/25/16)
    Earnings: EPS $0.88 Revenue $5.19B
    Estimates: EPS $0.95 Revenue $5.29B

    Up 0.23% today
     
  5. T0rm3nted

    T0rm3nted Moderator
    Staff Member

    Joined:
    Apr 2, 2016
    Messages:
    7,448
    Likes Received:
    2,453
    Upcoming dividend information:

    Ex-Div-Date
    : 11/10/16
    Payment Date: 12/9/16
    Dividend: $0.51
    Current Price: $72.65
    Annual Yield: 2.81%
     
  6. T0rm3nted

    T0rm3nted Moderator
    Staff Member

    Joined:
    Apr 2, 2016
    Messages:
    7,448
    Likes Received:
    2,453
  7. LloydWCoutee

    LloydWCoutee Active Member

    Joined:
    May 4, 2016
    Messages:
    721
    Likes Received:
    58
    Eli Lilly and Company's outperform rating reiterated at Credit Suisse Group. $87.00 PT.
     
  8. Gambit

    Gambit Active Member

    Joined:
    Oct 16, 2016
    Messages:
    703
    Likes Received:
    62
    Eli Lilly To Invest $850M in US Capital Projects $LLY
     
  9. Norman Foster

    Norman Foster New Member

    Joined:
    Sep 19, 2017
    Messages:
    10
    Likes Received:
    0
    In September, Eli Lilly decided to axe 3,500 employees and now it is planning to spinoff/sell Elanco business. What's happening in Lilly? http://alphastreet.com/be0ed58e
     
  10. emmett kelly

    emmett kelly Well-Known Member

    Joined:
    Dec 21, 2017
    Messages:
    469
    Likes Received:
    257
     
  11. darwin

    darwin New Member

    Joined:
    Jan 10, 2021
    Messages:
    4
    Likes Received:
    1
    20% up for Eli Lilly. The progress came after a promising result on the TRAILBLAZER-ALZ Phase 2 study, slowing Alzheimer’s the study shows.

    https://zyne.com/stock/LLY
     
    T0rm3nted likes this.

Share This Page